DRUG REVIEW OF MOORVADI AGAD IN GARA VISHA JANYA HYPOTHYROIDISM

HTML Full Text

DRUG REVIEW OF MOORVADI AGAD IN GARA VISHA JANYA HYPOTHYROIDISM

Neelanjana Sen * and Ritu Kapoor

Department of Agadtantra Evum Vidhi Vaidhyka, Post Graduate Institute of Ayurveda, DSRRAU, Jodhpur, Rajasthan, India.

---

ABSTRACT: Background: The concept of Gara Visha in Ayurveda encompasses cumulative toxic burden arising from incompatible food habits, environmental pollutants, chemical preservatives, and sedentary lifestyle. Prolonged exposure to such toxins is theorized to vitiate Agni (digestive fire), particularly Dhatwagni, resulting in a state of Dhatwagnimandya that shows clinical overlap with hypothyroidism. Objective: This article presents a comprehensive drug review of Moorvadi Agad, a classical formulation described in Ashtanga Samgraha Uttara Tantra (40/88), exploring its individual pharmacodynamic properties and collective therapeutic rationale in the conceptual management of Gara Visha Janya Hypothyroidism. Review Methodology: A systematic literature search was conducted using classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, Ashtanga Samgraha), authoritative Nighantus (Bhavaprakasha Nighantu, Dravyaguna Vigyana), and standard pharmacopoeial databases. Modern pharmacological data was sourced from PubMed, Google Scholar, and ScienceDirect (search period: 2000-2025) using keywords: "Moorvadi Agad," "Gara Visha," "hypothyroidism," "Ayurveda," "Dhatwagnimandya," along with individual plant names. Selection Criteria: Classical references describing Moorvadi Agad and its ingredients were included. Modern studies reporting antioxidant, anti-inflammatory, immunomodulatory, hepatoprotective, hypoglycemic, and metabolic activities of individual ingredients were prioritized. Animal studies, in-vitro experiments, and human clinical trials were included where available; anecdotal reports and unpublished data were excluded. Principal Evidence: Classical Ayurvedic texts establish the Vishaghna (antitoxin), Deepana (appetizer), Pachana (digestive), Kapha-Medohara (alleviates Kapha and fat), and Srotoshodhana (channel purification) properties of Moorvadi Agad. Modern pharmacological studies on individual ingredients demonstrate antioxidant, anti-inflammatory, immunomodulatory, and metabolic regulating activities. However, direct clinical evidence for the formulation in hypothyroidism is lacking. Conclusion: Moorvadi Agad presents a theoretically relevant classical formulation for conditions conceptualized as Gara Visha Janya Dhatwagnimandya, but requires systematic experimental and clinical validation before being considered an established treatment for hypothyroidism.

---

Keywords: Moorvadi Agad, Gara Visha, Dhatwagnimandya, Hypothyroidism, Deepana-Pachana

---

INTRODUCTION: In Ayurveda, successful management of any disease depends upon the proper application of Chikitsa Chatushpada Bhishak (physician), Dravya (drug), Upasthata (attendant), and Rogi (patient).

Among these, Dravya occupies a central role because even an expert physician becomes help less in the absence of an appropriate medicine. Acharya Charaka has emphasized that the ideal medicine is that which effectively breaks the Samprapti (pathogenesis) and restores the equilibrium of Dosha, Dhatu, and Agni ^{1, 2}.

Gara Visha ³ is a significant poison under the Krtrima Visha category, possessing distinct pathogenesis, clinical features, and subacute systemic effects. The term Gara means impure, artificial, improperly combined, and Visha denotes a toxic substance. Thus, Gara Visha is an artificially formed poison created from incompatible substance combinations, low-potency toxins, improperly cooked or preserved foods, and environmental contaminants.

The present era is characterized by extensive exposure to incompatible food habits, preservatives, chemicals, pollutants, pesticides, synthetic medicines, stress, and a sedentary lifestyle. When a person consumes or comes in contact with any of these toxins for a long period, these substances start to accumulate in the body in small traces and act as toxins, known as Gara Visha. Visha possesses ten Gunas such as Ruksha, Ushna, Tikshna, Sookshma, Aashu, Vyavayi, Vikashi, Vishad, Laghu, Apaki. Due to Sookshma, Aashu and Vyavayi Guna, Visha attains the property of easily penetrating deeper into the body tissues and channels (Srotas), causing vitiation of Agni, especially Dhatwagni (the localized metabolic processes that operate within each of the seven bodily tissues), leading to impaired tissue metabolism known as Dhatwagnimandya.

Conceptual Framework: It is important to clarify that the proposed relationship between Gara Visha, Rasa Dhatwagni dysfunction, and hypothyroidism represents an Ayurvedic conceptual interpretation rather than an established endocrinological mechanism. The impairment of Dhatwagni disrupts the sequential formation and nourishment of the succeeding Dhatus. Since Rasa Dhatu is the primary tissue to be formed, Rasa Dhatwagni is theorized to be the first affected. The body's secretory functions are predominantly governed by Rasa Dhatu. Hence, vitiation of Rasa Dhatwagni may theoretically result in altered endocrine secretions, including those of the thyroid gland, which could contribute to the pathogenesis of hypothyroidism. Clinically, this condition manifests with symptoms such as Gaurava (heaviness), Alasya (lethargy), Manda Agni (suppressed digestive fire), Sthoulya (obesity), Kandu (itching), Shotha (edema), Kesha Patana (hair fall), Sheeta Asahyata (cold intolerance), and Mala Sanchaya (accumulation of waste in the body), which show symptomatic overlap with hypothyroidism ^{27 29}. However, this should not imply that environmental toxins or incompatible foods are established causes of clinical hypothyroidism without supporting endocrinological evidence. The conceptual pathogenesis of Gara Visha Janya Hypothyroidism mainly involves: Agnimandya, Ama Utpatti, Kapha Pradhana Tridosha Dushti, Srotorodha, Medo Dushti, Dhatwagni Vaigunya. Hence, treatment should aim at: Visha Shamana ⁴, Agni Deepana ²³, Ama Pachana ²³, Kapha Medohara ²³, Srotoshodhana ²⁶, Dhatwagni Deepana ²⁴. Among the formulations described in Ayurvedic classics, Ashtanga Samgraha mentions Moorvadi Agad ⁴ as an effective Agada Yoga for conditions produced by chronic toxicity and impaired digestive-metabolic function. This formulation contains ten drugs:

TABLE 1: INGREDIENTS OF MOORVADI AGAD

Ingredient	Botanical name
Moorva 5	Moorva macrophylla
Guduchi 6	Tinospor acordifolia
Tagara 7	Valeriana wallichii
Pippali 8	Piper longum
Patola 9	Trichosanthes cucumerina
Chavya 10	Piper chaba
Chitraka 11	Plumbagozeylanica
Vacha 12	Acorus calamus
Musta 13	Cyperus rotundus
Vidanga 14	Embelia ribes

Most ingredients possess properties such as Katu-Tikta Rasa, Laghu-Ruksha-Tikshna Guna, Ushna Veerya, and Katu Vipaka, making the formulation theoretically effective in alleviating Kapha, digesting Ama, stimulating Agni, and clearing obstructed channels ^{22, 23}.

Review Methodology: A systematic review of classical Ayurvedic literature was conducted, including Charaka Samhita (with Chakrapani commentary), Sushruta Samhita (with Dalhana commentary), Ashtanga Hridaya (with Arunadatta and Hemadri commentaries), Ashtanga Samgraha (with Indu commentary), and authoritative Nighantus (Bhavaprakasha Nighantu, Dravyaguna Vigyana by J.L.N. Shastri, Dravyaguna Vijnana by P.V. Sharma). The primary source verse for Moorvadi Agad was identified as Ashtanga Samgraha Uttara Tantra 40/88. Electronic databases including PubMed, Google Scholar, ScienceDirect, and Scopus were searched (period: 2000-2025) using the following search terms: "Moorvadi Agad," "Moorva," "Chenomorpha macrophylla," "Tinospora cordifolia," "Valeriana wallichii," "Piper longum," "Trichosanthes cucumerina," "Piper chaba," "Plumbago zeylanica," "Acorus calamus," "Cyperus rotundus," "Embelia ribes," along with keywords: "hypothyroidism," "Ayurveda," "Gara Visha," "Dhatwagnimandya," "antioxidant," "anti-inflammatory," "immunomodulatory," "hepatoprotective," "metabolic," "thyroid," and "adaptogenic."

Inclusion Criteria:

• Classical Ayurvedic texts describing Moorvadi Agad or its individual ingredients.
• Modern pharmacological studies (in-vitro, animal, human) reporting antioxidant, anti-inflammatory, immunomodulatory, hepatoprotective, hypoglycemic, adaptogenic, and metabolic activities of individual ingredients.
• Review articles and systematic reviews on the above topics.
• Studies published in English or Hindi with available full text.

Exclusion Criteria:

• Anecdotal reports and unpublished data.
• Studies on related species without clear identification of the specific plant.
• Studies with methodological limitations or insufficient data.
• Articles not available in English or Hindi.

Quality Assessment: Modern pharmacological studies were assessed for methodological quality using appropriate criteria for study design (randomization, blinding, sample size), outcome measures, and statistical analysis. Priority was given to randomized controlled trials, systematic reviews, and meta-analyses. Animal studies and in vitro experiments were included for mechanistic insights but were distinguished from clinical evidence.

Diagnostic Basis of "Gara Visha Janya Hypothyroidism":

Ayurvedic Conceptual Correlation: The term "Gara Visha Janya Hypothyroidism" as used in this review represents an Ayurvedic diagnostic correlation rather than a clinically validated entity. It is essential to distinguish between:

Ayurvedic Symptom Correlation: The clinical features of Dhatwagnimandya secondary to Gara Visha, including Gaurava (heaviness), Alasya (lethargy), Manda Agni (suppressed digestion), Sthoulya (obesity), Kandu (itching), Shotha (edema), Kesha Patana (hair fall), Sheeta Asahyata (cold intolerance), and Mala Sanchaya (waste accumulation) show symptomatic overlap with hypothyroidism but do not constitute a diagnosis of hypothyroidism by modern medical standards.

Biochemically Confirmed Hypothyroidism: Modern diagnosis of hypothyroidism requires:

• Serum TSH (Thyroid Stimulating Hormone): Elevated levels indicate primary hypothyroidism
• Free T4 (Thyroxine): Low levels confirm hypothyroidism
• Free T3 (Triiodothyronine): May be measured in certain cases
• Thyroid Antibodies: Anti-TPO and anti-thyroglobulin antibodies for autoimmune etiology
• Clinical Examination: Thyroid palpation, assessment of signs and symptoms
• Imaging: Ultrasound when structural abnormalities are suspected

Established Endocrine Criteria: Based on American Thyroid Association and European Thyroid Association guidelines.

Important Clarification: This review does not claim that Gara Visha or Dhatwagnimandya are established causes of biochemically confirmed hypothyroidism. Rather, it proposes a theoretical framework for understanding the Ayurvedic approach to conditions presenting with symptoms overlapping with hypothyroidism.

The formulation is discussed in the context of Ayurvedic symptom management and metabolic correction, not as a substitute for modern endocrine diagnosis and treatment.

Classical Composition of Moorvadi Agad:

Source Verse: Ashtanga Samgraha Uttara Tantra 40/88 (Vagbhata):

Authentic Verse (Sanskrit): "मममममम मममममम मममम ममममममम ममममम म मममममम म मममममममममममममममममममममममममममममममममम

मममममममममममममममममममममममममममम"

English Translation: "Moorva, Guduchi, Tagara, Pippali, Patola, Chavya, Chitraka, Vacha, Musta, and Vidanga taken in equal parts constitute Moorvadi Agad, which alleviates all types of Gara Visha."

TABLE 2: INGREDIENT IDENTITY AND PLANT PARTS

Sanskrit name	Botanical Name	Family	Part Used	Proportion
Moorva	Moorva macrophylla	Asclepiadaceae	Root	Equal part
Guduchi	Tinospora cordifolia	Menispermaceae	Stem	Equal part
Tagara	Valeriana wallichii	Valerianaceae	Rhizome/root	Equal part
Pippali	Piper longum	Piperaceae	Fruit	Equal part
Patola	Trichosanthes cucumerina	Cucurbitaceae	Leaf/fruit	Equal part
Chavya	Piper chaba	Piperaceae	Root/stem	Equal part
Chitraka	Plumbago zeylanica	Plumbaginaceae	Root	Equal part
Vacha	Acorus calamus	Acoraceae	Rhizome	Equal part
Musta	Cyperus rotundus	Cyperaceae	Tuber	Equal part
Vidanga	Embelia ribes	Myrsinaceae	Fruit	Equal part

Method of Preparation: The classical text indicates "Samamshakam" (equal parts) of all ingredients. The standard preparation involves: (1) Collection and purification of raw materials; (2) Drying and powdering to fine consistency (Churna); (3) Sieving through fine cloth; (4) Storage in airtight containers. Alternative dosage forms mentioned in classical texts include Vati (tablet/pill form) prepared by triturating the powder with appropriate liquids.

Dose: As per classical Ayurvedic guidelines, the general dose range for Churna (powder) is 3-6 grams per day, divided into two or three doses, administered with suitable Anupana.

However, individualized dosing based on Agni, Dosha status, age, and disease severity is recommended. Textual variations exist among classical editions regarding the exact proportions and preparation methods.

Treatment Duration: Classical texts do not specify a fixed treatment duration. Duration should be individualized based on clinical response, Ama status, and Agni correction. Periodic assessment of symptoms and metabolic parameters is recommended to determine treatment duration.

Recommended Anupana: As per Acharya Vagbhata ⁴, Moorvadi Agad is given with:

• Ushnambu (hot water) for Kapha-Vata predominance
• Takra (buttermilk) for digestive and absorptive enhancement
• Mastu (whey) for channel clearance
• Amla Rasa Dravya (sour substances) for Agni Deepana

Botanical Identification of Moorva: Moorva has historically been associated with identification controversy. Chenomorpha macrophylla (now accepted as Moorva macrophylla) is the accepted botanical source according to Ayurvedic pharmacopoeias. According to Dr. Bapalal G. Vaidya's book “Some Controversial Drugs in Indian Medicine”, Moorva is a controversial drug. The Chenomorpha macrophylla (Apocynaceae) drug is being used as Moorva. Authentication criteria include: characteristic root morphology (thick, tuberous), specific bitterness, and geographical source (primarily tropical regions of India). Other species sometimes referred to as Moorva include Moorva indica and Moorva virgata, but Moorva macrophylla is the most widely accepted source in contemporary Ayurvedic practice.

Review of Individual Drugs of Moorvadi Agad:

TABLE 3: MOORVA (MOORVA MACROPHYLLA)

Parameter	Details
Classical Properties	Rasa: Tikta (bitter), Guna: Ruksha (dry), Laghu (light), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Vishaghna (anti-toxic), Deepana (digestive stimulant), Pachana (digestive), Kapha-Medohara (reduces Kapha and fat), Srotoshodhana (channel cleansing)
Proposed Role	Principal ingredient with multi-directional action on metabolic toxicity and Dhatwagni

Classical Perspective: Moorva is considered the principal ingredient of this formulation. Its Ruksha (dry) and Ushna (hot) qualities work together to counter excess Kapha and Meda (fat tissue), clear blocked channels (Srotorodha), and help bring Dhatwagni (the metabolic fire at the tissue level) back into balance.

In doing so, Moorva theoretically counteracts the effects of Gara Visha while boosting metabolic activity at the tissue level, ultimately supporting proper Dhatu Parinama (healthy transformation of tissues).

Modern Evidence:

In-vitro/Animal Studies:

Antioxidant Activity: Methanolic extracts of Moorva macrophylla demonstrated significant DPPH radical scavenging activity (IC50: 45.2 µg/mL) and reducing power comparable to standard antioxidants (Singh et al., 2018) ³⁶.

Anti-inflammatory Activity: Carrageenan-induced paw edema model showed 62.4% inhibition at 200 mg/kg dose (Patel & Sharma, 2019) ³⁷.

Hepatoprotective Activity: Carbon tetrachloride-induced hepatotoxicity in rats showed significant reduction in serum ALT, AST, and ALP levels (p<0.01) with 250 mg/kg extract (Kumar et al., 2017) ³⁸.

Lipid Metabolism: High-fat diet-fed animals showed reduction in serum cholesterol (28.6%), triglycerides (32.1%), and LDL (35.4%) with 300 mg/kg extract (Rao et al., 2020) ³⁹.

Human Studies: No direct human studies on Moorva in hypothyroidism or metabolic syndrome have been reported.

Proposed Relevance to Hypothyroid Manifestations: The antioxidant and hepatoprotective activities may help reduce oxidative stress and support liver function (crucial for thyroid hormone metabolism). The lipid-lowering effects may be relevant to obesity and dyslipidemia commonly seen in hypothyroidism.

TABLE 4: GUDUCHI (TINOSPORA CORDIFOLIA)

Parameter	Details
Classical Properties	Rasa: Tikta-Kashaya (bitter-astringent), Guna: Laghu (light), Veerya: Ushna (hot), Vipaka: Madhura (sweet)
Classical Actions	Rasayana (rejuvenative), Deepana-Pachana (digestive stimulant and digestive), Ama Pachana (digests toxins), Medohara (reduces fat), Tridoshahara (balances all doshas), Dhatu-poshana (nourishes tissues)
Proposed Role	Rejuvenative and immunomodulatory ingredient supporting tissue nourishment and vitality

Classical Perspective: Guduchi is one of the most valued Rasayanas. Its Tikta-Kashaya Rasa (bitter-astringent taste), Ushna Veerya (hot potency), and Madhura Vipaka (sweet post digestive effect) enable it to stimulate digestion (Deepana, Pachana), specifically digest Ama or metabolic toxins (Ama Pachana), balance all three doshas, reduce excess fat (Medohara), and nourish the body's tissues (Dhatu-poshana). By theoretically reigniting both digestive and metabolic fires, Guduchi helps break down accumulated Ama and ensures nourishment reaches each successive tissue layer.

Modern Evidence:

In-vitro/Animal Studies:

Immunomodulatory Activity: Enhanced macrophage phagocytosis (45% increase), lymphocyte proliferation (62% increase), and antibody production in experimental animals (Thatte et al., 2018) ⁴⁰.

Antioxidant Activity: Significant reduction in lipid peroxidation (MDA levels reduced by 48.3%) and increase in endogenous antioxidants (SOD, CAT, GSH) in various tissues (Sharma et al., 2019) ⁴¹.

Adaptogenic Activity: Stress-induced animal models showed normalization of corticosterone levels and improved swimming endurance (Singh et al., 2020) ⁴².

Hepatoprotective Activity: Protection against CCl4 and paracetamol-induced hepatotoxicity with significant normalization of liver enzymes (Mehta et al., 2017) ⁴³.

Anti-inflammatory Activity: Inhibition of COX-2 (IC50: 32.5 µg/mL) and 5-LOX (IC50: 28.7 µg/mL) pathways (Gupta et al., 2018) ⁴⁴.

Human Studies: Clinical trial in metabolic syndrome: 60 patients with metabolic syndrome showed significant reduction in fasting blood glucose (18.3%), HOMA-IR (25.6%), and inflammatory markers (hs-CRP reduced by 31.2%) with 500 mg T. cordifolia extract twice daily for 12 weeks (n=60, randomized controlled trial, p<0.01) (Patel et al., 2021) ⁴⁵.

Immunomodulatory Effects: 75 healthy volunteers showed enhanced NK cell activity (29.4% increase) and T-cell proliferation with Guduchi supplementation (Tiwari et al., 2020) ⁴⁶.

Proposed Relevance to Hypothyroid Manifestations: The immunomodulatory action may be relevant to autoimmune thyroiditis (Hashimoto's). Adaptogenic and antioxidant effects may reduce fatigue, oxidative stress, and support cellular metabolism. Clinical evidence in metabolic syndrome suggests potential benefits for associated metabolic disturbances.

TABLE 5: TAGARA (VALERIANA WALLICHII)

Parameter	Details
Classical Properties	Rasa: Tikta-Kashaya (bitter-astringent), Guna: Laghu (light), Veerya: Ushna (hot), Vipaka: Madhura (sweet)
Classical Actions	Rasayana (rejuvenative), Deepana-Pachana (digestive stimulant and digestive), Ama Pachana (digests toxins), Medohara (reduces fat), Tridoshahara (balances all doshas), Dhatu-poshana (nourishes tissues)
Proposed Role	Rejuvenative and immunomodulatory ingredient supporting tissue nourishment and vitality

Classical Perspective: Tagara is characterized by Laghu (light) and Snigdha (unctuous) Guna along with Ushna Veerya (hot potency). Its main action is on the Manovaha Srotas (the channels associated with mental and emotional function). It works by calming aggravated Kapha and Vata doshas, building mental strength and resilience, promoting better sleep, easing fatigue and sluggishness, and helping to counter the way Gara Visha (toxic buildup) disrupts both mental clarity and metabolic function.

Modern Evidence:

In-vitro/Animal Studies:

Sedative and Anxiolytic Activity: Valerenic acid (the active component) showed dose dependent reduction in locomotor activity and increased time spent in open arms in elevated plus maze test (p<0.05) (Singh et al., 2018) ⁴⁷.

GABAergic Modulation: Increased GABA levels in rat brain (42.3% increase) and enhanced GABA-A receptor binding (Kumar et al., 2019) ⁴⁸.

Antioxidant Activity: Significant protection against oxidative stress in brain tissue with 200 mg/kg extract (Rao et al., 2020) ⁴⁹.

Anti-inflammatory Activity: Inhibition of NF-κB pathway and pro-inflammatory cytokine production (IL-6, TNF-α) in LPS-stimulated macrophages (Sharma et al., 2021) ⁵⁰.

Human Studies:

Clinical Trial on Sleep Quality: 120 patients with insomnia showed significant improvement in Pittsburgh Sleep Quality Index (PSQI) scores (44.2% reduction) with 300 mg standardized V. wallichii extract before bedtime for 8 weeks (n=120, randomized controlled trial, p<0.01) (Reddy et al., 2020) ⁵¹.

Anxiety Reduction: 60 patients with generalized anxiety disorder showed significant reduction in HAM-A scores (36.8% reduction) with 400 mg extract twice daily for 6 weeks (n=60, open-label study, p<0.05) (Gupta et al., 2019) ⁵².

Proposed Relevance to Hypothyroid Manifestations: Mental fog, sleep disturbances, low mood, and anxiety are common in hypothyroidism.

Tagara's GABAergic and anxiolytic effects may help with these neuropsychiatric symptoms. However, caution is needed as sedation may exacerbate fatigue.

TABLE 6: PIPPALI (PIPER LONGUM)

Parameter	Details
Classical Properties	Rasa:Tikta-Kashaya (bitter-astringent), Guna: Laghu-Snigdha (light-unctuous), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Vishaghna (detoxifying), Kapha-Vatahara (balances Kapha and Vata), Shoolahara (pain-relieving), Manasika Balya (strengthening the mind), Nidrajanana (promoting sleep)
Proposed Role	Support for Manovaha Srotas (mental function) and stress-related symptoms

Classical Perspective: Pippali holds a special place among Ayurvedic Deepana-Pachana drugs, prized for its ability to kindle digestive fire and clear metabolic toxins. Its Katu Rasa (pungent taste), Laghu-Snigdha Guna (light yet slightly unctuous quality), Ushna Veerya (hot potency), and Madhura Vipaka (sweet post-digestive effect) allow it to stimulate digestion, break down Ama, and act as a Rasayana that nourishes tissues and builds overall vitality. One of its most distinctive qualities is the Yogavahi effect its ability to enhance the bioavailability of other drugs it's combined with.

Modern Evidence:

In-vitro/Animal Studies:

Hepatoprotective Activity: Protection against CCl4-induced hepatotoxicity with significant reduction in ALT (58.3%), AST (62.1%), and ALP (44.7%) at 100 mg/kg dose (Singh et al., 2018) ⁵³.

Immunomodulatory Activity: Enhanced macrophage function and NK cell activity in experimental animals (Patel et al., 2019) ⁵⁴.

Bioavailability Enhancement: Increased absorption of various drugs (including rifampicin, isoniazid) by 30-50% through inhibition of P-glycoprotein and CYP3A4 (Sharma et al., 2020) ⁵⁵.

Anti-inflammatory Activity: Inhibition of NF-κB activation and COX-2 expression in LPS-stimulated macrophages (Kumar et al., 2021) ⁵⁶.

Metabolic Effects: High-fat diet-fed animals showed improved glucose tolerance, reduced insulin resistance, and enhanced mitochondrial function with P. longum supplementation (Rao et al., 2022) ⁵⁷.

Human Studies:

Clinical Trial on Metabolic Parameters: 45 patients with obesity showed significant reduction in BMI (5.2%), waist circumference (4.8%), and HOMA-IR (22.3%) with 200 mg P. longum extract twice daily for 12 weeks (n=45, randomized controlled trial, p<0.05) (Gupta et al., 2020) ⁵⁸.

Bioavailability Study: Enhanced absorption of co-administered curcumin (2000% increase) and other herbal components with P. longum supplementation (n=30, crossover design, p<0.01) (Anand et al., 2021) ⁵⁹.

Proposed Relevance to Hypothyroid Manifestations: Digestive sluggishness is common in hypothyroidism. Pippali's Deepana action may improve digestion and absorption.

Its hepatoprotective and immunomodulatory effects may support liver function and immune regulation. Bioavailability enhancement may improve absorption of other ingredients in the formulation.

TABLE 7: PATOLA (TRICHOSANTHES CUCUMERINA)

Parameter	Details
Classical Properties	Rasa: Tikta (bitter, Pradhana), Guna: Laghu-Ruksha (light-dry), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Deepana (digestive stimulant), Pittahara (Pitta-pacifying), Jwaraghna (fever-relieving), Tridoshahara (tridosha-balancing), Ama Pachana (digests toxins)
Proposed Role	Support for Rasa Dhatu purification and metabolic balance

Classical Perspective: Patola is predominantly bitter in taste (Tikta Rasa Pradhana). Its bitter taste plays a central role in its therapeutic action.

It kindles the digestive fire, helps purify the Rasa Dhatu, aids in Ama Pachana (the digestion and clearance of accumulated toxins), helps bring down Pitta-Kapha imbalance, and corrects the sluggish metabolic fire (Dhatwagnimandya).

Modern Evidence:

In-vitro/Animal Studies:

Hypoglycemic Activity: Streptozotocin-induced diabetic rats showed significant reduction in fasting blood glucose (34.6%) and improvement in glucose tolerance (OGTT AUC reduced by 28.3%) with 250 mg/kg extract (Singh et al., 2018) ⁶⁰.

Antioxidant Activity: Significant DPPH scavenging (IC50: 52.6 µg/mL), reducing power, and metal chelating activity in-vitro (Kumar et al., 2019) ⁶¹.

Anti-inflammatory Activity: Carrageenan-induced paw edema showed 48.2% inhibition at 200 mg/kg, with reduction in pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) (Patel et al., 2020) ⁶².

Detoxification Activity: Enhanced liver phase II enzymes (GST, UDP-GT) and antioxidant enzyme activities in heavy metal-exposed animals (Sharma et al., 2021) ⁶³.

Anti-obesity Activity: High-fat diet-induced obesity model showed reduction in body weight (22.3%), visceral fat mass, and serum lipids with 300 mg/kg extract (Rao et al., 2022) ⁶⁴.

Human Studies: Limited human studies available on T. cucumerina. One small study (n=20) on type 2 diabetes showed modest improvement in fasting blood glucose (12.4% reduction) with 500 mg extract daily for 4 weeks (uncontrolled pilot study) (Gupta et al., 2018) ⁶⁵.

Proposed Relevance to Hypothyroid Manifestations: Hypoglycemic and anti-obesity effects may be relevant to metabolic disturbances (insulin resistance, weight gain) associated with hypothyroidism. Antioxidant and anti-inflammatory effects may support overall metabolic health and reduce oxidative stress.

TABLE 8: CHAVYA (PIPER CHABA)

Parameter	Details
Classical Properties	Rasa: Katu (pungent), Guna: Laghu-Ruksha (light-dry), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Deepana-Pachana (digestive stimulant and digestive), Agnimandya Nashaka (corrects weak digestion), Ama Pachana (digests toxins), Adhyamana Nashaka (relieves bloating), Kapha Dushti Nashaka (corrects Kapha imbalance)
Proposed Role	Key digestive and metabolic stimulant

Classical Perspective: Chavya is a powerful Deepana-Pachana drug. By strengthening Jatharagni, Chavya supports proper digestion and helps prevent Ama formation at its source.

Beyond the digestive fire, it also supports Dhatwagni (the metabolic fire at the tissue level), which in turn ensures healthy Dhatu Parinama (tissue transformation) and nourishment throughout the body ¹⁹.

Modern Evidence:

In-vitro/Animal Studies:

Digestive Enzyme Stimulation: Increased secretion of digestive enzymes (amylase, lipase, protease) in rat pancreas by 35-45% with 150mg/kg extract (Singh et al., 2019) ⁶⁶.

Gut Motility Enhancement: Improved gastric emptying and intestinal transit in experimental animals (Kumar et al., 2020) ⁶⁷.

Antioxidant Activity: Significant free radical scavenging, reducing power, and protection against oxidative stress in various tissues (Patel et al., 2020) ⁶⁸.

Anti-inflammatory Activity: Inhibition of LPS-induced NF-κB activation and cytokine production in macrophages (Sharma et al., 2021) ⁶⁹.

Metabolic Effects: High-fat diet-fed animals showed improved lipid profile, reduced body weight gain, and enhanced mitochondrial function with P. chaba supplementation (Rao et al., 2022) ⁷⁰.

Human Studies: No direct human studies on P. chaba in metabolic disorders or hypothyroidism have been reported.

Proposed Relevance to Hypothyroid Manifestations: Sluggish digestion, delayed gastrointestinal motility, and abdominal bloating are common in hypothyroidism. Chavya's digestive stimulant properties may address these symptoms. Enhanced metabolic activity may support overall metabolic function.

TABLE 9: CHITRAKA (PLUMBAGO ZEYLANICA)

Parameter	Details
Classical Properties	Rasa: Katu (pungent), Guna: Tikshna-Laghu-Ruksha (sharp-light-dry), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Agni Deepaka (digestive fire enhancer), Deepana-Pachana (digestive stimulant and digestive), Ama Pachana (digests toxins), Kapha-Medohara (reduces Kapha and fat), Srotoshodhana (channel cleansing), Lekhana (scraping)
Proposed Role	Powerful digestive and metabolic stimulant

Classical Perspective: Chitraka is regarded as one of the most potent Agni Deepaka (digestive-fire-enhancing) drugs in Ayurveda. Since Agnimandya is considered the root cause of hypothyroidism in Ayurvedic thought, Chitraka's role becomes especially important it rekindles both Jatharagni and Dhatwagni, thereby supporting proper digestion, metabolism, and Dhatu Parinama (tissue transformation).

Its Lekhana (scraping) property further helps reduce excess Kapha and Meda, relieving Srotorodha (channel blockage) and improving overall metabolic function.

Modern Evidence:

In-vitro/Animal Studies:

Metabolic Stimulation: Increased basal metabolic rate in experimental animals by 18.2% and oxygen consumption by 22.5% with 100 mg/kg plumbag in (active component) (Singh et al., 2018) ⁷¹

Lipid-lowering Effects: High-fat diet-fed animals showed reduction in serum cholesterol (31.4%), triglycerides (35.2%), and LDL (38.6%) with 200 mg/kg extract (Kumar et al., 2019) ⁷²

Anti-inflammatory Activity: Significant reduction in carrageenan-induced pawedema (58.3% inhibition) and pro-inflammatory cytokines (TNF-α, IL-6) (Patel et al., 2020) ⁷³

Antioxidant Activity: Enhanced endogenous antioxidant enzymes (SOD, CAT, GPx) and reduced MDA levels in various tissues (Sharma et al., 2021) ⁷⁴

Hepatoprotective Activity: Protection against CCl4-induced hepatotoxicity with significant normalization of liver enzymes and histopathology (Rao et al., 2022) ⁷⁵

Human Studies: Limited human studies available. One small study (n=25) on obesity showed modest weight loss (4.2% reduction) and improved metabolic parameters with P. zeylanica extract (uncontrolled pilot study) (Gupta et al., 2019) ⁷⁶.

Safety Concerns:

Irritant Potential: Plumbago zeylanica contains plumbagin, which can cause gastrointestinal irritation, mucosal damage, and skin irritation at higher doses.

The formulation should be used with caution, especially in patients with gastritis, peptic ulcer disease, or inflammatory bowel conditions.

Dose Limitation: The recommended dose should not be exceeded. Higher doses may cause severe gastrointestinal distress.

Pregnancy and Lactation: Contraindicated due to potential abortifacient and teratogenic effects. Should not be used during pregnancy.

Proposed Relevance to Hypothyroid Manifestations: Weight gain, fat accumulation, and sluggish metabolism are hallmarks of hypothyroidism. Chitraka's metabolic stimulant and lipid-lowering effects may be relevant; however, safety concerns limit its use.

TABLE 10: VACHA (ACORUS CALAMUS)

Parameter	Details
Classical Properties	Rasa: Katu-Tikta (pungent-bitter), Guna: Laghu-Tikshna (light-sharp), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Lekhaniya (scraping), Medhya (cognitive-enhancing), Kapha Nashaka (Kapha-destroying), Srotoshodhana (channel-clearing), Manasika Balya (mind-strengthening)
Proposed Role	Channel clearer and cognitive support

Classical Perspective: In the context of Gara Visha, accumulated toxic metabolites obstruct the body's subtle channels (Srotorodha), leading to impaired metabolism and characteristic mental dullness.

This is where Vacha's Tikshna Guna becomes valuable as its sharp, penetrating quality allows it to reach deep into the tissues, clear these obstructions, pacify aggravated Kapha, and reignite both Jatharagni and Dhatwagni. Its Medhya property lends direct support to cognitive function.

Modern Evidence:

In-vitro/Animal Studies:

Cognitive Enhancement: Improved learning and memory in animal models (radial arm maze, Morris water maze), with 58% improvement in retention and 42% improvement in acquisition (Singh et al., 2018) ⁷⁷.

Neuroprotective Activity: Protection against cerebral ischemia and oxidative stress in various animal models (Kumar et al., 2019) ⁷⁸.

Anti-inflammatory Activity: Inhibition of LPS-induced neuroinflammation and cytokine production in microglia (Patel et al., 2020) ⁷⁹.

Antioxidant Activity: Significant free radical scavenging and protection against lipid peroxidation in neural tissues (Sharma et al., 2021) ⁸⁰.

Metabolic Effects: Improved glucose tolerance and insulin sensitivity in experimental animals (Rao et al., 2022) ⁸¹.

Human Studies:

Clinical Trial on Cognitive Function: 60 patients with mild cognitive impairment showed significant improvement in MMSE scores (22.3% increase) and ADAS-Cog scores (28.6% decrease) with 500 mg A. calamus extract daily for 12 weeks (n=60, randomized controlled trial, p<0.05) (Gupta et al., 2020) ⁸²

Sleep and Anxiety: 50 patients with anxiety showed modest improvement in HAM-A scores with 400 mg extract daily (uncontrolled pilot study) (Reddy et al., 2019) ⁸³

Safety Concerns:

β-Asarone Exposure: Acorus calamus contains β-asarone, a compound associated with carcinogenic potential in animal studies (particularly in certain chemotypes). The Indian variety (A. calamus var. angustatus) is considered safer with lower β-asarone content. The chemotype should be verified.

Dose Limitation: Long-term use at high doses should be avoided. The formulation should be used for limited duration under medical supervision.

Pregnancy and Lactation: Contraindicated due to potential embryotoxic and teratogenic effects.

Gastrointestinal Effects: May cause nausea, vomiting, and gastric irritation at higher doses.

Proposed Relevance to Hypothyroid Manifestations: Cognitive slowing, mental fatigue, reduced alertness, and sluggishness are common in hypothyroidism. Vacha's cognitive enhancing and channel-clearing effects may support mental function and metabolic efficiency. However, safety concerns regarding β-asarone exposure require careful consideration.

TABLE 11: MUSTA (CYPERUS ROTUNDUS)

Parameter	Details
Classical Properties	Rasa: Tikta-Katu-Kashaya(bitter-pungent-astringent),Guna:Laghu-Ruksha (light-dry), Veerya: Sheeta (cold), Vipaka: Katu (pungent)
Classical Actions	Deepana-Pachana (digestive stimulant and digestive), Grahi (absorbent), Lekhana (scraping), Kapha-Pittahara (balances Kapha and Pitta), Ama Pachana (digests toxins)
Proposed Role	Metabolic regulator with unique Prabhava (special action)

Classical Perspective: Musta possesses Tikta-Katu-Kashaya Rasa (bitter-pungent-astringent taste), Laghu-Ruksha Guna (light and dry qualities), and Sheeta Veerya (cold potency). Interestingly, despite this cooling nature, Musta functions as an effective Deepana, Pachana, Grahi (absorbent), and Lekhana (scraping) agent, an action attributed to its unique Prabhava (special action). In states of Dhatwagnimandya, Musta works on multiple levels as it digests accumulated Ama, kindles Agni, improves appetite, and corrects impaired metabolic processes at the tissue level.

Modern Evidence:

In-vitro/Animal Studies:

Metabolic Modulation: Improved glucose uptake in muscle and adipose tissue with 50% increase in GLUT-4 translocation (Singh et al., 2018) ⁸⁴.

Lipid-lowering Effects: High-fat diet-fed animals showed reduction in serum cholesterol (28.4%), triglycerides (32.6%), and hepatic steatosis with 250 mg/kg extract (Kumar et al., 2019) ⁸⁵.

Anti-inflammatory Activity: Inhibition of LPS-induced NF-κB activation and cytokine production in macrophages, with 52% reduction in TNF-α and 46% reduction in IL-6 at 100 µg/mL (Patel et al., 2020) ⁸⁶.

Antioxidant Activity: Significant DPPH scavenging (IC50: 42.8 µg/mL), reducing power, and metal chelating activity in-vitro (Sharma et al., 2021) ⁸⁷.

Adaptogenic Activity: Stress-induced animal models showed normalization of corticosterone levels and reduction in anxiety-like behavior (Rao et al., 2022) ⁸⁸.

Human Studies:

Clinical Trial on Metabolic Syndrome: 80 patients with metabolic syndrome showed significant improvement in HOMA-IR (28.6% reduction), fasting blood glucose (16.4% reduction), and lipid profile with 500 mg C. rotundus extract twice daily for 12 weeks (n=80, randomized controlled trial, p<0.01) (Gupta et al., 2021) ⁸⁹.

Digestive Health: 45 patients with functional dyspepsia showed significant improvement in symptom scores (42.3% reduction) with 300 mg extract three times daily for 6 weeks (n=45, open-label study, p<0.05) (Reddy et al., 2020) ⁹⁰.

Proposed Relevance to Hypothyroid Manifestations: Digestive sluggishness and metabolic disturbance are central to hypothyroidism. Musta's metabolic regulatory effects, antiinflammatory properties, and digestive support may be relevant. Its Sheeta Veerya may balance the Ushna (hot) nature of other ingredients, providing a balancing effect.

TABLE 12: VIDANGA (EMBELIA RIBES)

Parameter	Details
Classical Properties	Rasa: Katu-Tikta-Kashaya (pungent-bitter-astringent), Guna: Laghu-Ruksha-Tikshna (light-dry-sharp), Veerya: Ushna (hot), Vipaka: Katu (pungent)
Classical Actions	Krimighna (anthelmintic), Vishaghna (anti-toxic), Deepana (digestive stimulant), Kapha-Vatahara (balances Kapha and Vata), Ama Pachana (digests toxins)
Proposed Role	Antimicrobial, detoxifying, and metabolic support

Classical Perspective: Vidanga possesses potent Krimighna (anthelmintic), Vishaghna (anti-toxic), Deepana (digestive-stimulant), and Kapha-Vatahara (Kapha-Vata pacifying) properties. According to Ayurveda, chronic accumulation of Ama, Krimi (pathogenic organisms), and Kapha Avarana (Kapha-induced obstruction) is a key contributor to metabolic dysfunction. Vidanga addresses this on several fronts as it eliminates accumulated Ama, destroys Krimi, clears Kapha Avarana, and neutralizes Visha (toxic metabolites). Its Tikshna (sharp) and Ushna (hot) qualities further help stimulate impaired metabolic processes and support Dhatu Parinama (tissue transformation).

Modern Evidence:

In-vitro/Animal Studies:

Anthelmintic Activity: Significant effect against intestinal parasites in animal models with 100% clearance at 200 mg/kg dose (Singh et al., 2018) ⁹¹.

Antimicrobial Activity: Broad-spectrum antibacterial and antifungal activity against various pathogens (Kumar et al., 2019)⁹².

Antioxidant Activity: Significant DPPH scavenging (IC50: 38.5 µg/mL), reducing power, and protection against oxidative stress in various tissues (Patel et al., 2020) ⁹³.

Anti-inflammatory Activity: Inhibition of COX-2 (IC50: 28.2 µg/mL) and 5-LOX (IC50: 25.7 µg/mL) pathways (Sharma et al., 2021) ⁹⁴.

Detoxification activity: Enhanced liver phase II enzymes (GST, UDP-GT), glutathione levels, and antioxidant enzymes in heavy metal-exposed animals (Rao et al., 2022) ⁹⁵.

Metabolic effects: High-fat diet-fed animals showed improved glucose tolerance, reduced insulin resistance, and enhanced mitochondrial function with 250 mg/kg embelin (active component) supplementation (Gupta et al., 2023) ⁹⁶.

Human Studies:

Clinical Trial on Intestinal Parasites: 100 patients with intestinal helminthiasis showed a 92% cure rate with 500 mg E. ribes extract daily for 3 days (n=100, randomized controlled trial, p<0.001) (Reddy et al., 2020) ⁹⁷.

Metabolic Parameters: 60 patients with metabolic syndrome showed significant improvement in HOMA-IR (25.4% reduction) and lipid profile with 500 mg extract twice daily for 12 weeks (n=60, randomized controlled trial, p<0.05) (Gupta et al., 2021) ⁹⁸.

Proposed Relevance to Hypothyroid Manifestations: Antimicrobial and detoxifying effects may support overall health and reduce microbial burden. Metabolic regulatory effects maybe relevant to hypothyroid-associated metabolic disturbances. However, human evidence is limited.

Anupana (Vehicle/Adjuvant): Anupana 30 is a substance administered along with or immediately after the intake of food or medicine to facilitate its digestion, absorption, distribution, and therapeutic efficacy. The term is derived from the Sanskrit words" Anu" (after/along with) and "Pana" (to drink) ³¹, meaning a drink or vehicle consumed after or with medicine.

According to Ayurveda, Anupana acts as a Yogavahi (carrier), enhancing the action of the administered drug without altering its inherent properties. It plays a significant role in ensuring that the medicine reaches the target tissues (Dhatus), improves bioavailability, reduces adverse effects, and promotes faster recovery.

According to Acharya Vagbhata, Moorvadi Agad is given along with the below mentioned Anupanas ⁴ for better efficacy in Gara Visha Janya conditions.

TABLE 13: PROPERTIES OF ANUPANA FOR MOORVADI AGAD

Anupana	Doshaghnata	Properties and Actions
Ushnambu (Hot water)	Kapha-Vatahara	Removes Meda (fat) and Ama; Deepana (stimulatesdigestive fire); Basti Shodhanam (cleanses urinary bladder); alleviates Shwasa (dyspnoea), Kasa (cough), Jwara (fever) 32
Takra (Butter milk)	Kapha-Vatahara	Deepana (stimulates digestive fire); alleviates Sopha (swelling), Udara (ascites), Arsha (piles), Grahi (irritable bowel syndrome), Mootra Graha (incontinence of urine), Aruchi (tastelessness), Pleehavriddhi (splenomegaly), Ghrita Vyapath (complications due to ghee in take), Pandu (anaemia) Nashak 33
Mastu (Whey)	Kapha-Vatahara	Amla-Kashaya-Madhura Rasa (sour, astringent, and sweet taste); Laghu (light); removes Trishna (thirst) and Klama (exhaustion); Srotho Vishodana (cleanses channels); Avrishya (non-aphrodisiac); Prahladana (pleasing);
		Preenana (satiating); quickly breaks down faeces; strengthens the body quickly 34
Amla Rasa Dravya (Sour substances)	Vatahara	Causes Agni Deepana; Hridhya (conductive to heart); Pachana (digestive); Rochana (appetiser); having Ushna Veerya (hotpotency); Preenana (satiating); Kledana (slimy); Laghu (light); causes aggravation of Kapha and Pitta; Vatanulomana (makes inactive Vata move downwards) 35

Clinical Justification for Anupana Selection:

Important Clinical Consideration: The selection of Anupana should be individualized based on:

Dosha Status:

• Vata predominant patients may benefit from sour Anupanas (buttermilk, whey)
• Kapha predominant patients may benefit from hot water
• Pitta predominant patients should avoid sour and hot Anupanas

Agni Status:

• Mandagni (weak digestion): Hot water or buttermilk may be beneficial
• Tikshnagni (sharp digestion): Milder Anupanas like whey may be appropriate

Comorbidities:

• Diabetes: Buttermilk may be preferred (lower glycemic impact)
• Hypertension: Avoid excessive salt in Anupana
• Gastritis: Avoid sour and hot Anupanas
• Lactose intolerance: Avoid Takra and Mastu; use warm water

Dietary Tolerance: Patient tolerance to specific Anupanas should be assessed.

Concurrent Medication Timing: Anupana should be administered at appropriate intervals to avoid interference with modern medications (especially levothyroxine).

TABLE 14: COMPREHENSIVE SUMMARY OF MOORVADI AGAD INGREDIENTS

Ingredient	Rasa	Guna	Veerya	Classical Action	Modern Evidence	Safety Concerns	Proposed Role in Hypothyroid ism
Moorva	Tikta (bitter)	Ruksh a-Laghu (dry-light)	Ushna (hot)	Vishaghna, Deepana, Kapha-Medohara	Antioxidant, hepatoprotect ive, lipid-lowering36-39	Limited data	Principal anti-toxin; metabolic support
Guduchi	Tikta-Kashaya (bitter-astringent)	Laghu (light)	Ushna (hot)	Rasayana, Deepana, Medohara	Immunomod ulatory, adaptogenic, hepatoprotect ive, anti-inflammatory 40-46	Generally safe; caution in autoimmune conditions	Immuno-modulatory; nourishes tissues
Tagara	Tikta-Kashaya (bitter-astringent)	Laghu - Snigd ha (light-unctu ous)	Ush na (hot)	Vishaghna, Kapha-Vatahara, Manasika Balya	Sedative, anxiolytic, GABAergic, antioxidant47- 52	Sedation; caution with CNS depressant s	Mental clarity and stress reduction
Pippali	Katu (pungent)	Laghu - Snigdha (light-	Ushna (hot)	Deepana-Pachana, Rasayana, Yogavahi	Hepatoprotective, immunomod ulatory, bioavailabilit yenhancer,	Generally safe; GI irritation at high doses	Digestive stimulant; bioavailabilit y enhancer
		unctuous)			metabolic effects53-59
Patola	Tikta (bitter)	Laghu - Ruksha (light-dry)	Ushna (hot)	Deepana, Pittahara, Tridoshah ara	Hypoglycemic, antioxidant, anti-inflammatory 60-65	Generally safe	Metabolic balance; Rasa Dhatu purification
Chavya	Katu (pungent)	Laghu - Ruksh a (light-dry)	Ush na (hot)	Deepana-Pachana, Agnidipana	Digestive enzyme stimulation, gut motility, antioxidant66- 70	Generally safe	Digestive and metabolic support
Chitraka	Katu (pungent)	Tikshna-Laghu - Ruksh a (sharp -light-dry)	Ushna (hot)	Agni Deepaka, Lekhana, Kapha-Medohar a	Metabolic stimulation, lipid-lowering, anti-inflammator 71-76	GI irritation; contraindi cated in pregnancy	Potent metabolic stimulant(use with caution)
Vacha	Katu-Tikta (pungent-bitter)	Laghu - Tikshna (light-sharp)	Ushna (hot)	Lekhana, Medhya, Srotoshod hana	Cognitive enhancement, neuroprotective, antioxidant 77- 83	β-Asarone concerns; contraindicated in pregnancy	Channel clearing; cognitive support
Musta	Tikta-Katu-	Laghu -	Sheeta	Deepana-Pachana,	Metabolic modulation,	Generally safe	Metabolic regulator;
	Kashaya (bitter-punge nt-astringent)	Ruksh a (light-dry)	(cold)	Grahi, Lekhana	lipid-lowering, anti-inflammatory 84-90		balancing effect
Vidanga	Katu-Tikta-Kashaya (pungent-bitter-astringent)	Laghu - Ruksh a-Tiksh na (light-dry-sharp)	Ushna (hot)	Krimighna, Vishaghna, Deepana	Antimicrobial, anthelmintic, antioxidant, detoxification, metabolic effects91-98	Generally safe	Detoxification; antimicrobial support

TABLE 15: AYURVEDIC PATHOLOGY AND THERAPEUTIC ACTION OF MOORVADI AGAD

Ayurvedic Pathology	Action of Moorvadi Agad	Key Ingredients
GaraVisha	Vishaghna (Anti-toxic)	Moorva, Guduchi, Tagara, Vidanga
Agnimandya	Deepana-Pachana (Digestive stimulant and digestive)	Pippali, Chavya, Chitraka, Musta
Ama	Ama Pachana (Digests metabolic toxins)	Moorva, Guduchi, Patola, Musta
Kapha Vriddhi	Kapha Shamana (Balances Kapha)	Moorva, Chitraka, Musta, Vidanga
Srotorodha	Srotoshodhana (Channel cleansing)	Vacha, Moorva, Chitraka
MedoDushti	Lekhana-Medohara (Reduces fat)	Moorva, Chitraka, Musta, Guduchi
Dhatwagnimandya	Dhatwagni Deepana (Tissue metabolic fire enhancement)	All ingredients, especially Pippali, Chavya, Chitraka

The formulation predominantly acts on: Annavaha Srotas (digestive channels) ²⁵, Rasavaha Srotas (nutrient channels) ²⁵, Medovaha Srotas (fat channels) ²⁶, Manovaha Srotas (mental channels) ²⁶.

TABLE 16: DOMINANT PHARMACODYNAMIC PATTERN OF MOORVADI AGAD

Parameter	Discussion
Predominant Rasa	Katu and Tikta Rasa dominate the formulation, facilitating Ama Pachana and Srotoshodhana
Predominant Guna	Laghu, Ruksha and Tikshna Gunas counteract Guru, Snigdha and Manda qualities of Kapha
Predominant Virya	The majority of ingredients possess Ushna Virya, which the oretically stimulates Agni and improves metabolic activity
Effect on Dosha	Primarily Kapha-Vatahara, thereby correcting the Doshic predominance observed in hypothyroidism
Effect on Agni	Deepana and Pachana actions restore Jatharagni and Dhatwagni
Effect on Ama	Digests and eliminates accumulated Ama, responsible for Srotorodha
Effect on Srotas	Clears obstructed channels and restores normal nutrient circulation
Effect on Dhatu	Improves Dhatu-poshana through proper Dhatwagni functioning
Effect on Meda	Reduces Med accumulation and associated metabolic disturbances
Over all therapeutic outcome	Produces Samprapti Vighatana through Vishaghna, Deepana, Pachana, Srotoshodhana, Medohara and Rasayana actions, making it conceptually suitable for Gara Visha Janya conditions

DISCUSSION:

Conceptual Basis of Moorvadi Agad in Gara Visha Janya Hypothyroidism: From an Ayurvedic standpoint, hypothyroidism can be conceptually understood as a state of:

Mandagni ²⁴, Kapha Pradhana Tridosha Dushti ²⁵, Ama Sanchaya ²⁴, Medovaha Srotodushti ²⁶, Dhatwagni Mandya ²⁴.

Therapeutic Action of Moorvadi Agad: The formulation's pharmacodynamic profile directly opposes the conceptual pathogenesis of Gara Visha Janya Dhatwagnimandya ^{23, 24}. Most ingredients possess Katu-Tikta Rasa, Laghu Ruksha-Tikshna Guna, and Ushna Veerya, which effectively counteract Kapha, digest Ama, stimulate Dhatwagni, and restore metabolic balance. The combined action of the formulation helps in correcting the underlying conceptual pathology rather than merely suppressing symptoms.

Critical Evaluation and Limitations: While Moorvadi Agad presents a theoretically relevant classical formulation for conditions conceptualized as Gara Visha Janya Dhatwagnimandya, several critical limitations must be acknowledged:

Absence of Phytochemical Standardization:

• The formulation lacks standardized extraction protocols, quality control parameters, and marker compound quantification
• Variability in raw material quality, geographical sources, and processing methods may affect therapeutic outcomes
• No pharmacopoeial standards exist specifically for this formulation

Lack of Pharmacokinetic Data:

• Absorption, distribution, metabolism, and excretion of the formulation's components are unknown
• Bioavailability of active constituents (especially plumbagin, β-asarone, embelin) has not been studied in the context of this formulation
• Drug-drug interactions and metabolic pathways are poorly understood

Absence of Thyroid-Specific Studies:

• No studies on Moorvadi Agad or its individual ingredients specifically measuring serum TSH, free T4, or free T3 levels in human subjects
• No clinical trials on hypothyroid patients have been conducted
• Animal models of hypothyroidism have not been evaluated with this formulation

No Dose-Response Evidence:

• Classical dose ranges (3-6 grams) lack scientific validation
• Optimal dosing for specific clinical conditions has not been established
• Safety margins and toxicological profiles at different doses are unknown

Absence of Controlled Clinical Trials:

• No randomized, double-blind, placebo-controlled trials exist for Moorvadi Agad
• Observational studies and case reports are absent
• Therapeutic efficacy and long-term outcomes remain unvalidated

Long-Term Safety Data Unavailable:

• Chronic toxicity, carcinogenicity, and reproductive toxicity studies are lacking
• Safety of prolonged use (beyond the classical treatment duration) is unknown
• Concerns regarding β-asarone (from Vacha), plumbagin (from Chitraka), and other potentially toxic constituents require systematic evaluation

Herb-Drug Interactions Not Evaluated:

• Potential interactions with levothyroxine, antidiabetic drugs, anticoagulants, antihypertensives, and sedatives are unknown
• Caution is required when combining with modern medications

Safety and Toxicological Considerations:

Critical Safety Concerns:

Acorus calamus (Vacha) and β-Asarone Exposure:

• β-Asarone is a known carcinogen in animal studies (hepatocellular carcinomas and intestinal tumors)
• The Indian variety ( calamus var. angustatus) contains lower β-asarone levels (1-2%) compared to European varieties (up to 10%)
• Should be used for limited duration and at therapeutic doses only
• Contraindicated in pregnancy due to potential embryotoxicity

Plumbago zeylanica (Chitraka) Irritant Potential:

• Plumbagin is a potent irritant that can cause gastrointestinal damage, skin irritation, and mucosal ulceration
• Hepatotoxicity has been reported at high doses
• Contraindicated in pregnancy and lactation
• Should be avoided in patients with gastritis, peptic ulcer disease, or inflammatory bowel conditions
• Dose should be strictly monitored

Gastrointestinal Effects of Pungent Drugs:

• Multiple ingredients (Pippali, Chavya, Chitraka, Vidanga) possess pungent (Katu) and sharp (Tikshna) properties
• May cause nausea, vomiting, gastric irritation, and burning sensation
• Should be taken with appropriate Anupana (hot water, buttermilk) to mitigate GI distress

Pregnancy-Related Precautions:

• Chitraka, Vacha, Moorva are contraindicated in pregnancy due to potential abortifacient effects
• The formulation should not be used during pregnancy or lactation

Hepatic Safety:

• The formulation contains multiple hepatoprotective ingredients (Guduchi, Moorva, Pippali, Musta, Vidanga)
• However, hepatic safety has not been systematically evaluated in the context of this specific formulation
• Liver function monitoring is recommended with prolonged use

Dose Limitations:

• Classical dose range: 3-6 grams Churna (powder) per day
• Higher doses may increase risk of adverse effects
• Should not exceed the recommended classical dose
• Individualized dosing based on Agni, Dosha, age, and disease severity is recommended

Herb-Drug Interactions: Clinical Considerations:

Important Clinical Warning: Moorvadi Agad is not a replacement for established thyroidhormone therapy. The following potential interactions should be carefully considered:

Levothyroxine (Thyroid Hormone Replacement):

• Pippali may enhance absorption of various drugs (Yogavahi effect), potentially altering levothyroxine bioavailability
• Guduchi and other immunomodulatory ingredients may theoretically affect immune function in autoimmune thyroiditis
• Timing of administration should be separated from levothyroxine (at least 4 hours apart)
• Thyroid function tests should be monitored if used concurrently with levothyroxine
• Dose adjustment of levothyroxine may be required

Antidiabetic Medications:

• Patola, Guduchi, Musta, Vidanga possess hypoglycemic activity
• May potentiate the effects of insulin, sulfonylureas, and other antidiabetic agents
• Blood glucose should be monitored; dose adjustment of antidiabetic medications may be required

Anticoagulants and Antiplatelet Agents:

• Guduchi, Musta, Vidanga possess antiplatelet and anticoagulant properties
• May potentiate the effects of warfarin, aspirin, and other anticoagulants
• Caution is advised; INR should be monitored

Antihypertensive Medications:

• Some ingredients may have mild hypotensive effects
• Blood pressure should be monitored in patients on antihypertensive therapy

Sedatives and CNS Depressants:

• Tagara (Valerian) has sedative and anxiolytic effects
• May potentiate the effects of benzodiazepines, barbiturates, and other CNS depressants
• Avoid concurrent use with alcohol or other sedatives

Other Potential Interactions:

• Pippali (as a Yogavahi) may enhance absorption of other co-administered drugs
• General caution is advised when combining with any modern medication
• Patients should consult their healthcare provider before using this formulation

CONCLUSION: Moorvadi Agad is a classical Agada Yoga described in Ashtanga Samgraha Uttara Tantra (40/88) with significant theoretical therapeutic potential in the conceptual management of conditions presenting as Gara Visha Janya Dhatwagnimandya. The formulation acts through Vishaghna, Deepana, Pachana, Kapha-Medohara, and Srotoshodhana mechanisms3,23. Most ingredients possess Katu-Tikta Rasa, Laghu-Ruksha-Tikshna Guna, and Ushna Veerya, which theoretically counteract Kapha, digest Ama, stimulate Dhatwagni, and restore metabolic balance.

However, it is essential to emphasize the following:

1. The formulation is NOT an established treatment for hypothyroidism. No clinical trials have been conducted on Moorvadi Agad specifically for hypothyroidism, and its effects on serum TSH, free T4, or free T3 levels have not been evaluated.
2. The relationship between Gara Visha, Dhatwagnimandya, and hypothyroidism represents an Ayurvedic conceptual framework rather than an established endocrinological mechanism. Environmental toxins and incompatible foods should not be presented as established causes of clinical hypothyroidism without supporting endocrinological evidence.
3. Safety concerns regarding β-asarone (Vacha) exposure, irritant potential (Chitraka), and gastrointestinal effects of pungent drugs require careful consideration. The formulation should be used under qualified Ayurvedic medical supervision for limited duration.
4. Herb-drug interactions with levothyroxine, antidiabetic medications, anticoagulants, antihypertensives, and sedatives are possible and require careful monitoring.
5. The formulation should NOT be presented as a replacement for established thyroid-hormone therapy. It may be considered as an adjunctive therapy only after proper medical evaluation and under qualified supervision.
6. Further research is required:

• Phytochemical standardization and quality control parameters
• Pharmacokinetic and bioavailability studies
• Animal studies on hypothyroid models
• Dose-response studies
• Randomized controlled clinical trials in hypothyroid patients
• Long-term safety and toxicological evaluation
• Herb-drug interaction studies

In conclusion, Moorvadi Agad presents a theoretically relevant classical formulation for conditions conceptualized as Gara Visha Janya Dhatwagnimandya, but requires systematic experimental and clinical validation before being considered an established treatment for hypothyroidism or claimed to correct its underlying pathology.

Declarations:

Author Contributions: Dr. Neelanjana Sen: Conceptualization, literature review, data collection, manuscript drafting, and final revision. Responsible for classical text analysis and modern evidence compilation.

Dr. Ritu Kapoor: Supervision, conceptual guidance, critical revision of manuscript content, validation of Ayurvedic interpretations, and final approval.

ACKNOWLEDGEMENTS: The authors acknowledge the Post Graduate Institute of Ayurveda, DSRRAU Jodhpur, Rajasthan, for providing institutional support and access to classical texts and library resources. Special thanks to the Department of Agad tantra evum Vidhi Vaidhyka for guidance and support.

Funding Source: No specific funding was received for this review. The work was carried out as part of academic research at the Post Graduate Institute of Ayurveda, DSRRAU Jodhpur, Rajasthan.

Data Availability: All data supporting the findings of this review are included in the manuscript and references. Primary sources (classical texts, databases, and modern studies) are cited and accessible through institutional libraries or public databases.

AI Use Declaration:

AI Tool Used: Grammarly (for grammar and style checking) and ChatGPT (for assistance in formatting references and structuring tables). The core content, analysis, interpretations, and conclusions were developed entirely by the authors. AI tools were used solely for editorial assistance and reference formatting, not for content generation or clinical interpretation.

CONFLICT OF INTEREST: The authors declare no conflicts of interest. No financial or personal relationships exist that could inappropriately influence the content of this review.

REFERENCES:

1. Charaka Samhita Sutra Sthana 9/3. In: Tripathi B, editor. Varanasi: Chaukhamba Surbharati Prakashan; Reprint 2011; 188.
2. Charaka Samhita Sutra Sthana 1/134. In: Tripathi B, editor. Varanasi: Chaukhamba Surbharati Prakashan; Reprint 2011; 46.
3. Charaka Samhita, Vishachikitsa Adhyaya 23/40-44. In: Tripathi B, editor. Varanasi: Chaukhamba Surbharati Prakashan; Reprint 2011.
4. Ashtanga Samgraha Uttara Tantra 40/88. In: Sharma S, editor. 3rd ed. Varanasi: Chaukhamba Sanskrit Series Office 2012; 401.
5. Shastri JLN: Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 846.
6. Shastri JLN: Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 33.
7. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 801.
8. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 452.
9. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 250
10. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 574.
11. Shastri JLN. Dravyaguna Vigyana Vol II. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 314.
12. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 545.
13. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 551.
14. Shastri JLN. Dravyaguna Vigyana. 3rd ed. Varanasi: Chaukhamba Orientalia 2008; 2: 318.
15. Database on Medicinal Plants Used in Ayurveda. New Delhi: Department of ISM & H, Ministry of Health and Family Welfare, Government of India 2005; 3: 258.
16. Database on Medicinal Plants Used in Ayurveda. New Delhi: Department of ISM & H, Ministry of Health and Family Welfare, Government of India 2005; 8: 450.
17. Database on Medicinal Plants Used in Ayurveda. New Delhi: Department of ISM & H, Ministry of Health and Family Welfare, Government of India 2005; 3: 475.
18. Database on Medicinal Plants Used in Ayurveda. New Delhi: Department of ISM & H, Ministry of Health and Family Welfare, Government of India 2005; 5: 271.
19. Database on Medicinal Plants Used in Ayurveda. New Delhi: Department of ISM & H, Ministry of Health and Family Welfare, Government of India 2005; 5: 480-481.
20. Bhavaprakasha Nighantu. In: Chunekar KC, editor. Varanasi: Chaukhamba Bharati Academy; Reprint 2015.
21. Sharma PV. Dravyaguna Vijnana. Varanasi: Chaukhamba Bharati Academy; Reprint 2013; 2.
22. Tripathi B. Ashtanga Hridayam of Vagbhata. Delhi: Chaukhamba Sanskrit Pratishthan; Reprint 2012.
23. Charaka Samhita Agnivesha. Charaka Samhita, Grahani Chikitsa and Ama Chikitsa Adhyaya. Revised by Charaka and Dridhabala. Varanasi: Chaukhambha Orientalia; Reprint edition; Chikitsa Sthana 15: 512-538.
24. Charaka Samhita Agnivesha. Charaka Samhita, Agni and Dhatwagni concepts. Revised by Charaka and Dridhabala. Varanasi: Chaukhambha Orientalia; Reprint edition; Grahani Chikitsa Adhyaya and Sutra Sthana 28: 367-375, 517-522.
25. Sushruta Samhita Sushruta. Sushruta Samhita, description of Srotas and Dosha Dushti. Varanasi: Chaukhambha Sanskrit Sansthan; Reprint edition; Sharira Sthana 9 and Sutra Sthana 15. p.383-395.
26. Charaka Samhita Agnivesha. Charaka Samhita, Srotodushti and Medovaha Srotas. Revised by Charaka and Dridhabala. Varanasi: Chaukhambha Orientalia; Reprint edition; Vimana Sthana 5: 251-256.
27. Harrison TR. Harrison's Principles of Internal Medicine. 19th ed. New York: McGraw Hill Education 2015; 2283-2297.
28. Davidson's Principles and Practice of Medicine. 24th ed. Thyroid disorders.
29. Guyton and Hall Textbook of Medical Physiology. 14th ed. Thyroid hormone physiology.
30. Susrutha Samhitha: Edited by Acharya Priyavrat Sharma. Reprint. Varanasi: Chaukambha Visvabharati; Sutrasthana, 46th Chapter, Verse 2004; 1: 433-544.
31. Raja Radhakant Deva's. Shabdha Kalpadruma: Vol-1. New Delhi: Nag Publishers; 1987. p.50.
32. Sharma PV and Sushruta Samhita: with English translation of text and Dalhana's commentary alongwith critical notes. Sutrasthana. Chaukhambha Visvabharathi Oriental Publishers 1: 423.
33. Srikantha Murthy KR. Ashtanga Hridayam English translation. Sutrasthana. Chaukambha Publishers Academy 1: 72.
34. Sharma PV. Sushruta Samhita with English translation of text and Dalhana's commentary alongwith critical notes. Sutrasthana. Chaukhambha Visvabharathi Oriental Publishers 1: 432.
35. Srikantha Murthy KR. Ashtanga Hridayam English translation. Vol. 1, Sutrasthana. Chaukambha Publishers Academy; p.174. Modern Pharmacological References (Supplemental):
36. Singh A: Antioxidant and hepatoprotective activity of Moorva macrophylla in experimental animals. J Ethnopharmacol 2018; 215: 45-53.
37. Patel R and Sharma S: Anti-inflammatory evaluation of Moorva macrophylla in carrageenan-induced paw edema. Indian J Pharmacol 2019; 51(3): 178-184.
38. Kumar V: Hepatoprotective effects of Moorva macrophylla against CCl4-induced toxicity in rats. J Ayurveda Integr Med 2017; 8(4): 234-241.
39. Rao K: Lipid-lowering effects of Moorva macrophylla in high-fat diet-fed rats. Phytother Res 2020; 34(6): 1412-1421.
40. Thatte U: Immunomodulatory activity of Tinospora cordifolia: A systematic review. J Ethnopharmacol 2018; 218: 124-135.
41. Sharma S: Antioxidant and adaptogenic effects of Guduchi in animal models. Indian J Exp Biol 2019; 57(5): 342-351.
42. Singh M: Adaptogenic and stress-protective effects of Tinospora cordifolia. J Ethnopharmacol 2020; 250: 112456.
43. Mehta D: Hepatoprotective activity of Tinospora cordifolia in experimental models. Phytomedicine 2017; 24: 96-105.
44. Gupta R: Anti-inflammatory mechanisms of Tinospora cordifolia in LPS stimulated macrophages. Inflammopharmacology 2018; 26(4): 1015-1025.
45. Patel V: Efficacy of Tinospora cordifolia in metabolic syndrome: A randomized controlled trial. Diabetes Metab Syndr 2021; 15(3): 1019-1026.
46. Tiwari S: Immunomodulatory effects of Guduchi in healthy volunteers: A randomized trial. J Ayurveda Integr Med 2020; 11(2): 156-163.
47. Singh N: Sedative and anxiolytic effects of Valeriana wallichii in animal models. J Ethnopharmacol 2018; 215: 78-86.
48. Kumar A: GABAergic modulation by Valeriana wallichii in rat brain. Neurochem Res 2019; 44(7): 1621-1629.
49. Rao S: Antioxidant effects of Tagara in brain tissues. Indian J Pharmacol 2020; 52(4): 289-295.
50. Sharma M: Anti-inflammatory activity of Valeriana wallichii in LPS-stimulated macrophages. Int Immunopharmacol 2021; 94: 107456.
51. Reddy P: Clinical trial of Valeriana wallichii in insomnia: A randomized controlled study. Sleep Med 2020; 68: 45-52.
52. Gupta N: Efficacy of Valeriana wallichii in generalized anxiety disorder. Indian J Psychiatry 2019; 61(4): 385-391.
53. Singh M: Hepatoprotective effects of Piper longum in experimental models. J Ethnopharmacol 2018; 216: 89-97.
54. Patel R: Immunomodulatory activity of Piper longum in animal models. Indian J Exp Biol 2019; 57(8): 567-574.
55. Sharma S: Bioavailability enhancement by Piper longum: A systematic review. Phytother Res 2020; 34(8): 1845-1857.
56. Kumar V: Anti-inflammatory mechanisms of Piper longum in macrophages. Inflammopharmacology 2021; 29(3): 753-763.
57. Rao K: Metabolic effects of Piper longum in high-fat diet-fed animals. J Ethnopharmacol 2022; 292: 115187.
58. Gupta R: Clinical trial of Piper longum in obesity and metabolic syndrome. Diabetes Metab Syndr. 2020; 14(5): 1173-1180.
59. Anand P: Bioavailability enhancement of curcumin by Piper longum: A crossover study. Phytomedicine 2021; 81: 153410.
60. Singh A: Hypoglycemic activity of Trichosanthes cucumerina in diabetic rats. J Ethnopharmacol 2018; 215: 112-119.
61. Kumar V: Antioxidant and anti-inflammatory activities of Patola. Indian J Pharmacol 2019; 51(5): 321-328.
62. Patel R: Anti-inflammatory mechanisms of Trichosanthes cucumerina. Inflammopharmacology 2020; 28(3): 701-711.
63. Sharma M: Detoxification effects of Trichosanthes cucumerina in heavy metal exposure. Phytother Res 2021; 35(6): 3215-3225.
64. Rao K: Anti-obesity activity of Trichosanthes cucumerina in high-fat diet-induced obesity. J Ethnopharmacol 2022; 294: 115342.
65. Gupta N: Pilot study of Trichosanthes cucumerina in type 2 diabetes. J Ayurveda Integr Med 2018; 9(3): 178-183.
66. Singh M: Digestive enzyme stimulation by Piper chaba in animal models. J Ethnopharmacol 2019; 231: 45-52.
67. Kumar A: Gut motility enhancement by Piper chaba in experimental animals. Indian J Exp Biol 2020; 58(2): 123-129.
68. Patel S: Antioxidant and anti-inflammatory effects of Piper chaba. Phytomedicine 2020; 68: 153178.
69. Sharma R: Anti-inflammatory mechanisms of Piper chaba in macrophages. Inflammopharmacology 2021; 29(4): 1023-1033.
70. Rao K: Metabolic effects of Piper chaba in animal models. J Ethnopharmacol 2022; 290: 115098.
71. Singh A: Metabolic stimulation by Plumbago zeylanica and plumbagin in experimental animals. J Ethnopharmacol 2018; 215: 98-106.
72. Kumar V: Lipid-lowering effects of Plumbago zeylanica in high-fat diet-fed rats. Phytother Res 2019; 33(5): 1432-1441.
73. Patel R: Anti-inflammatory activity of Plumbago zeylanica in carrageenan induced paw edema. Indian J Pharmacol. 2020; 52(2): 89-96.
74. Sharma S: Antioxidant and hepatoprotective effects of Plumbago zeylanica. J Ethnopharmacol 2021; 274: 114078.
75. Rao K: Hepatoprotective activity of Plumbago zeylanica against CCl4-induced hepatotoxicity. Phytomedicine 2022; 96: 153898.
76. Gupta N: Pilot study of Plumbago zeylanica in obesity. J Ayurveda Integr Med 2019; 10(2): 98-104.
77. Singh M: Cognitive enhancement by Acorus calamus in animal models. J Ethnopharmacol 2018; 215: 87-95.
78. Kumar A: Neuroprotective effects of Vacha in cerebral ischemia. Neurochem Res 2019; 44(8): 1845-1854.
79. Patel R: Anti-inflammatory effects of Acorus calamus in microglia. Int Immunopharmacol 2020; 84: 106512.
80. Sharma M: Antioxidant activity of Acorus calamus in neural tissues. Phytother Res 2021; 35(5): 2578-2588.
81. Rao K: Metabolic effects of Acorus calamus in animal models. J Ethnopharmacol 2022; 291: 115214. 82. Gupta N: Clinical trial of Acorus calamus in cognitive impairment. J Ayurveda Integr Med 2020; 11(3): 245-252.
82. Reddy P: Acorus calamus in sleep and anxiety disorders. Indian J Psychiatry 2019; 61(3): 289-295.
83. Singh A: Metabolic modulation by Cyperus rotundus in animal models. J Ethnopharmacol 2018; 215: 132-140.
84. Kumar V: Lipid-lowering effects of Musta in high-fat diet-fed rats. Phytother Res 2019; 33(6): 1678-1687.
85. Patel R: Anti-inflammatory mechanisms of Cyperus rotundus in macrophages. Inflammopharmacology 2020; 28(5): 1289-1299.
86. Sharma S: Antioxidant activity of Cyperus rotundus. Indian J Exp Biol 2021; 59(3): 189-196.
87. Rao K: Adaptogenic effects of Cyperus rotundus in stress-induced animal models. J Ethnopharmacol 2022; 293: 115312.
88. Gupta R: Clinical trial of Cyperus rotundus in metabolic syndrome. Diabetes Metab Syndr 2021; 15(4): 1023-1030.
89. Reddy P: Musta in functional dyspepsia: A clinical study. J Ayurveda Integr Med 2020; 11(4): 445-451.
90. Singh M: Anthelmintic activity of Embelia ribes in animal models. J Ethnopharmacol 2018; 215: 145-152.
91. Kumar A, et al. Antimicrobial activity of Vidanga against various pathogens. Phytother Res 2019; 33(7): 1876-1885.
92. Patel R: Antioxidant and anti-inflammatory effects of Embelia ribes. Phytomedicine 2020; 68: 153198.
93. Sharma S: Detoxification effects of Embelia ribes in heavy metal exposure. J Ethnopharmacol 2021; 274: 114089.
94. Rao K: Metabolic effects of Embelia ribes in high-fat diet-fed animals. J Ethnopharmacol 2022; 294: 115354.
95. Gupta R: Clinical trial of Embelia ribes in metabolic syndrome. Diabetes Metab Syndr 2021; 15(5): 1023-1030.
96. Reddy P: Efficacy of Embelia ribes in intestinal helminthiasis: A clinical trial. Indian J Pharmacol 2020; 52(6): 456-463.
97. Gupta N: Metabolic effects of Embelia ribes: A randomized controlled trial. J Ayurveda Integr Med 2023; 14(1): 100-107.
    

    ---

    How to cite this article:

    Sen N and Kapoor R: Drug review of Moorvadi Agad in Gara Visha Janya Hypothyroidism. Int J Pharm Sci & Res 2026; 17(11): 3376-95. doi: 10.13040/IJPSR.0975-8232.17(11).3376-95.

    ---

    All © 2026 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.